Diagnostics & Imaging Week articles from September 2002

Diagnostics & Imaging Week archives from September 2002

Rapid test might solve puzzle of West Nile transmission.
September 5, 2002... Diagnostics & Imaging Week Managing Editor The bioterrorism agent anthrax currently has what is probably an even more dangerous parallel in a natural infectious disease: West Nile virus. For both, only a small minority of those...

Orchid BioSciences to apply SNP analysis to WTC effort.
September 5, 2002... Diagnostics & Imaging Week Staff Writer Almost a year after the Sept. 11 tragedy, more than half of the victims at New York's World Trade Center remain unidentified. While about 49% of the nearly 3,000 killed as a result of the...

Evotec licensing model keeps it a step ahead in tough times. (Report from Europe).
September 5, 2002... A Diagnostics & Imaging Week Staff Report Evotec OAI (Hamburg, Germany) licensed its patented technology for analysis of certain gene fragments in polymerase chain reactions to Roche Diagnostics GmbH (Mannheim, Germany), an affiliate of F....

Flow of laboratory automation products continues unabated. (Report from Europe).
September 5, 2002... Diagnostics & Imaging Week Contributing Writer A major area of new product development activity in clinical diagnostics is automated lab systems, particularly systems for automation of chemistry and immunochemistry testing. While automated...

NIH licenses, collaborations lead to breakthrough products.
September 5, 2002... Diagnostics & Imaging Week Contributing Writer Government-funded laboratories perform some 20% of the biomedical, biotechnology and pharmaceutical research in the U.S. and are the leaders in technology transfer. Most of this research is...

Fischer imaging revenues dip; '02 sales down for Biomerica. (Earnings roundup).
September 5, 2002... A Diagnostics & Imaging Week Staff Report Fischer Imaging (Denver, Colorado) said revenues for the second quarter ended June 30 declined to $9.1 million from $12.8 million in the year-earlier period. The 2002 quarter excludes one-time...

No answer yet from FTC, so Quest in extension on Unilab. (Deals roundup).
September 5, 2002... A Diagnostics & Imaging Week Staff Report Quest Diagnostics (Teterboro, New Jersey) extended for the sixth time the expiration date for its cash election exchange offer for all outstanding shares of Unilab (Tarzana, California) common...

Hologic (Bedford, Massachusetts), a provider of women's diagnostic imaging systems and digital radiography systems, completed a $32.3 million sale-leaseback transaction for two of its properties with W.P. Carey & Co. (Deals roundup).
September 5, 2002... Hologic (Bedford, Massachusetts), a provider of women's diagnostic imaging systems and digital radiography systems, completed a $32.3 million sale-leaseback transaction for two of its properties with W.P. Carey & Co. (New York), an investment...

VitalLabs (Clearwater, Florida) entered into employment agreements with the two sole stockholders of Bayshore Laboratories. (Deals roundup).
September 5, 2002... VitalLabs (Clearwater, Florida) entered into employment agreements with the two sole stockholders of Bayshore Laboratories in Pasco County, Florida. The agreements require the employees to provide 100% of Bayshore's book of physician...

Abbott recalls gonorrhea kits that may give false negatives.
September 5, 2002... Diagnostics * Imaging Week Washington Editor WASHINGTON -- Abbott Laboratories (Abbott Park, Illinois) is voluntarily withdrawing certain lots of its gonorrhea test kits at risk for giving false negative results. The announcement came...

Akubio. (People In Places).
September 5, 2002... John Pritchard was named CEO of Akubio (Cambridge, UK). Pritchard previously was the vice president of research and development for diagnostic products at Genzyme. Akubio employs acoustic detection technology developed at the University of...

Beckman Coulter. (People In Places).
September 5, 2002... Linda Crans was promoted from vice president-director to vice president of manufacturing and integrated supply chain services at Beckman Coulter (Fullerton, California). Beckman Coulter develops instruments, chemistries, software and supplies...

Bio-Reference Laboratories. (People In Places).
September 5, 2002... Bader Maria Pedemonte-Coira, MD, was promoted from medical director to vice president and chief medical officer for Bio-Reference Laboratories. Pedemonte will continue to oversee GenPath, the company's cancer laboratory. Bio-Reference...

Enterix. (People In Places).
September 5, 2002... Craig Sands was named president and CEO of Enterix (Falmouth, Maine). Most recently, Sands was vice president of sales and marketing and vice president of managed care for Cytyc. Enterix develops diagnostics and makes !nSure, a brush-based...

EP Medsystems. (People In Places).
September 5, 2002... Reinhard Schmidt was promoted to CEO of EP Medsystenm (West Berlin, New Jersey), a post previously held by company founder David Jenkins, who will remain chairman. Schmidt joined the company last year as president and chief operating officer,...

Paradigm Medical Industries. (People In Places).
September 5, 2002... Thomas Motter resigned as director, chairman and CEO of Paradigm Medical Industries (Salt Lake City, Utah). The board added that it removed Mark Miehle as president and chief operating officer, though he entered into a consulting agreement with...

Anwar Padhani was named associate medical director of oncology for Synarc (San Francisco, California), a radiology service focused on imaging and molecular markers for clinical trials. (People In Places).
September 5, 2002... Anwar Padhani was named associate medical director of oncology for Synarc (San Francisco, California), a radiology service focused on imaging and molecular markers for clinical trials. He will retain the clinical lead role in magnetic resonance...

Amersham Biosciences. (Product Briefs).
September 5, 2002... Amersham Biosciences (Piscataway, New Jersey) launched the Lucidea SlidePro Hybridizer, which automates the hybridization step of microarray applications. The instrument automates slide pretreatment, non-static hybridization, stringency washes...

Applied Biosystems (Foster City, California) introduced the Cleavable ICAT Reagent Technology for protein expression analysis, designed to offer a powerful mass spectrometry-based method for preparing and analyzing complex samples for identifying expression levels of proteins in complex biological samples. (Product Briefs).
September 5, 2002... Applied Biosystems (Foster City, California) introduced the Cleavable ICAT Reagent Technology for protein expression analysis, designed to offer a powerful mass spectrometry-based method for preparing and analyzing complex samples for...

Cepheid. (Product Briefs).
September 5, 2002... Cepheid (Sunnyvale, California) reported receiving U.S. patent No. 6,440,725, covering apparatus and methods for the capture of cells and microorganisms on a filter or membrane and the extraction, purification, concentration and elution of...

Fred Hutchinson Cancer Research Center. (Product Briefs).
September 5, 2002... The Fred Hutchinson Cancer Research Center (Seattle, Washington) received FDA clearance for the lupus screening test developed by its researchers. The Anti-SR protein antibody assay involves adding sera to tiny wells in a plastic plate that has...

Genentech. (Product Briefs).
September 5, 2002... Genentech (South San Francisco, California) received FDA approval for its supplemental biological license application to include information about a breast cancer gene-detection test method called FISH (fluorescence in situ hybridization, or...

PharmaNetics (Raleigh, North Carolina) received FDA clearance to market the Enox Test, a rapid, point-of-care test to detect the anticoagulant effects of enoxaparin sodium developed in collaboration with Aventis Pharmaceuticals (Bridgewater, New Jersey). (Product Briefs).
September 5, 2002... PharmaNetics (Raleigh, North Carolina) received FDA clearance to market the Enox Test, a rapid, point-of-care test to detect the anticoagulant effects of enoxaparin sodium developed in collaboration with Aventis Pharmaceuticals (Bridgewater,...

Growth seen in POC testing, along with home use segment.
September 12, 2002... The hospital-based point-of-care (POC) market and self-testing products are two clinical diagnostic sectors that continue to attract investment by suppliers. The POC hemostasis testing products segment is advancing on two fronts. There is...

Rapid growth eyed for colon cancer screening developer.
September 12, 2002... Just hearing the words colon cancer makes many people shudder. Not only is the disease a feared killer, but its screening tests are renowned for their unpleasant nature. But Enterix (Falmouth, Maine), founded five years ago in Australia and...

Assays address limitations of HIV viral resistance testing. (Report from Europe).
September 12, 2002... In spite of the continual development of new antiretroviral drugs, the problem of rapid viral mutations often results in resistance developing against new therapeutics. Viral resistance testing is therefore necessary whenever patients show...

HandyLab's genetic POC system to be both handier and handheld.
September 12, 2002... "Handy" is the handle that Kalyan Handique, PhD, has been given at the company he co-founded and used by the growing number of scientists working with the firm. The nickname is appropriate in several ways, since the company's name is HandyLab...

Human genome sequences will improve disease management.
September 12, 2002... A comparison of the Human Genome Project's public and private sequences has turned up a number of duplicated segments that may contain disease-related genes. The study also provides a valuable resource for generating a finished version of the...

FDA OK triggers milestone for Cygnus from Sankyo. (Financings roundup).
September 12, 2002... Cygnus (Redwood City, California) received a fourth and final milestone payment from Sankyo Pharma, a wholly owned U.S. subsidiary of Sankyo Co. (Tokyo), resulting from recent FDA clearance for the GlucoWatch G2 Biographer by children and...

Applied Imaging. (Financings roundup).
September 12, 2002... Applied Imaging (Santa Clara, California) reported that it has extended and expanded its existing loan facility with Silicon Valley Bank, with the amended loan agreement providing Applied Imaging with an increase in borrowing capability to $3.5...

EPMedSystems (EPMD; West Berlin, New Jersey) received the first of a series of equity investments from Boston Scientific (Natick, Massachusetts) as part of a joint-development project in the field of electrophysiology. (Financings roundup).
September 12, 2002... EPMedSystems (EPMD; West Berlin, New Jersey) received the first of a series of equity investments from Boston Scientific (Natick, Massachusetts) as part of a joint-development project in the field of electrophysiology. EPMD holds a substantial...

TomoTherapy. (Financings roundup).
September 12, 2002... TomoTherapy (Madison, Wisconsin) completed a $9 million round of equity funding. The company recently received FDA 510(k) clearance for its HI-ART Image Guided IMRT Radiotherapy System for the treatment of cancer. The company said it would use...

GPO enters into a contract with cardiac imaging firm. (Agreements roundup).
September 12, 2002... Membership-based healthcare group purchasing organization AmeriNet (St. Louis, Missouri) signed a contract with Camtronics Medical Systems (Hartland, Wisconsin), a subsidiary of Analogic, for Camtronics' Vericis for Cardiology Image and...

Axeda Systems (Mansfield, Massachusetts), a provider of device relationship management (DRM) enterprise software and services, said that Applied Biosystems Group (AB; Foster City, California), an Applera Corp. business and a provider of DNA analyzers, will use its DRM system in its new ABI Prism 3730/3730xl DNA Analyzers. (Agreements roundup).
September 12, 2002... Axeda Systems (Mansfield, Massachusetts), a provider of device relationship management (DRM) enterprise software and services, said that Applied Biosystems Group (AB; Foster City, California), an Applera Corp. business and a provider of DNA...

TSE rapid test comparisons. (Report from Europe).
September 12, 2002... The French food safety authority (AFSSA) published results of a small study comparing the rapid transferable spongiform encephalopathy (TSE) tests currently available to test for the presence of scrapie prions in sheep and goats, as well, of...

Anthrax research agreement. (Report from Europe).
September 12, 2002... Regma BioTechnologies (London), which is developing antibiotics based on bacteriophages, has signed a research agreement with the U.S. Naval Medical Research Center (Silver Springs, Maryland) for the development of diagnostics and therapeutics...

Bio-Reference Laboratories. (Earnings Roundup).
September 12, 2002... Bio-Reference Laboratories (Elmwood Park, New Jersey) reported record net income of $1.5 million or 12 cents a diluted share in the third quarter ended July 31, up from $619,835 or 5 cents a share in the year-earlier period. Revenues grew to...

Elbit Medical Imaging. (Earnings Roundup).
September 12, 2002... Elbit Medical Imaging (Tel Aviv, Israel) said revenues in the first six months ended June 30 grew to NIS 426 million (about $89 million) from NIS 317 million (about $67 million) in the first half of last year. Net income totaled NIS 7.7 million...

Atherotech. (People in Places).
September 12, 2002... Michael Peat, PhD, was named vice president of operations for Atherotech (Birmingham, Alabama). Previously, Peat was president of the substance abuse testing division at LabOne. Atherotech is a cardiodiagnostic company and specialty reference...

BD. (People in Places).
September 12, 2002... BD (Franklin Lakes, New Jersey) reported the death of board member Albert Costello, 66, on Sept. 3. Costello joined BD's board of directors in 1996. Costello retired as chairman, president and CEO of W.R. Grace & Co. in 1999. He earlier was...

Charles River Laboratories International. (People in Places).
September 12, 2002... Nancy Gillett, PhD, was named corporate vice president of drug discovery and development as well as the president of the Sierra Biomedical Division of Charles River Laboratories International (Wilmington, Massachusetts). Since 1999 Cillett has...

Daxor. (People in Places).
September 12, 2002... Richard Prall was appointed vice president and national sales manager for Daxor (New York). Prall most recently was eastern sales manager for Toshiba America Medical Systems. Daxor makes the BVA-100, a semi-automated blood volume analyzer used...

Fisher Scientific International. (People in Places).
September 12, 2002... Patrick Balthrop was named president of Fisher HealthCare, a division of Fisher Scientific International (Hampton, New Hampshire). Balthrop previously was corporate vice president of the vascular devices business of Abbott Laboratories. Fisher...

MetaProbe. (People in Places).
September 12, 2002... William Dow, PhD, was named vice president of research and development for MetaProbe (San Diego, California). Dow most recently was vice president of chemical research and development at Pharmacyclics. MetaProbe develops imaging agents enabling...

Micro Therapeutics. (People in Places).
September 12, 2002... Thomas Wilder III was appointed president and CEO of Micro Therapeutics (Irvine, California). Wilder previously was vice president and general manager of the endovascular stent grafts division of Medtronic. Micro Therapeutics manufactures...

DiaDexus (South San Francisco, California) entered into a research agreement with the University of Michigan (Ann Arbor, Michigan) to use proteomic technologies for the comprehensive analysis of cell surface membrane proteins to identify new drug targets and biomarkers useful to treat and diagnose cancer. (Agreements roundup).
September 12, 2002... DiaDexus (South San Francisco, California) entered into a research agreement with the University of Michigan (Ann Arbor, Michigan) to use proteomic technologies for the comprehensive analysis of cell surface membrane proteins to identify new...

Hologic (Bedford, Massachusetts), a provider of women's diagnostic imaging systems and general digital radiography systems, was awarded a multi-year contract with the Defense Supply Center of Philadelphia (DSCP; Philadelphia, Pennsylvania). (Agreements roundup).
September 12, 2002... Hologic (Bedford, Massachusetts), a provider of women's diagnostic imaging systems and general digital radiography systems, was awarded a multi-year contract with the Defense Supply Center of Philadelphia (DSCP; Philadelphia, Pennsylvania). The...

SurroMed (Mountain View, California) entered into a pilot biomarker discovery collaboration with Eli Lilly and Co. (Indianapolis, Indiana). (Agreements roundup).
September 12, 2002... SurroMed (Mountain View, California) entered into a pilot biomarker discovery collaboration with Eli Lilly and Co. (Indianapolis, Indiana). Lilly will supply preclinical samples for analysis in SurroMed's Biomarker Discovery Laboratory using...

U.S. Genomics (Woburn, Massachusetts) was awarded by the Defense Advanced Research Projects Agency a $499,500 contract to examine the use of its direct linear DNA analysis technology to detect Class A pathogens, such as anthrax and smallpox. (Agreements roundup).
September 12, 2002... U.S. Genomics (Woburn, Massachusetts) was awarded by the Defense Advanced Research Projects Agency a $499,500 contract to examine the use of its direct linear DNA analysis technology to detect Class A pathogens, such as anthrax and smallpox....

Xtrana (Broomfield, Colorado) entered into a multi-year exclusive distribution agreement with Marsh Bio Products (Rochester, New York) to market and sell Xtrana's Xtra Amp Nucleic Acid Extraction Kits in the U.S. Xtrana develops nucleic acid extraction kits and detection systems for use in molecular diagnostics, drug discovery, forensics, research, clinical and life sciences markets. (Agreements roundup).
September 12, 2002... Xtrana (Broomfield, Colorado) entered into a multiyear exclusive distribution agreement with Marsh Bio Products (Rochester, New York) to market and sell Xtrana's Xtra Amp Nucleic Acid Extraction Kits in the U.S. Xtrana develops nucleic acid...

Charles River Laboratories International. (Product Briefs).
September 12, 2002... Charles River Laboratories International (Wilmington, Massachusetts) released Endosafe IPT, an in vitro test kit that provides a non-animal method for detecting harmful microbial contamination in drugs, medical devices and a range of other...

Gen-Probe. (Product Briefs).
September 12, 2002... Gen-Probe (San Diego, California) reported results from the first trial of its Tigris System, an automated NAT system for testing in clinical labs and in testing donated blood. In a field evaluation that tested Tigris on more than 6,500...

IMI International Medical Innovations. (Product Briefs).
September 12, 2002... IMI International Medical Innovations (Toronto, Ontario) received CE mark approval for its skin cholesterol test, Cholesterol 1,2,3, a non-invasive cholesterol test system. It is cleared for use as part of risk assessment for coronary artery...

Ischemia Technologies. (Product Briefs).
September 12, 2002... Ischemia Technologies (Denver, Colorado) said Canadian regulatory authorities granted marketing approval for its Albumin Cobalt Binding test, used to detect acute cardiac conditions in patients with chest pain. The test is available in Europe,...

North American Scientific. (Product Briefs).
September 12, 2002... North American Scientific (Chatsworth, California) reported at last week's Congress of the European Association of Nuclear Medicine in Vienna, Austria, results of a Phase I study for safety, biodistribution and dosimetry of its Hynic-Annexin V...

Quidel. (Product Briefs).
September 12, 2002... Quidel (San Diego, California) received a U.S. patent for its Layered Thin Film technology covering its use in dried external positive and/or negative controls for many types of diagnostic tests, supplementing the built-in, specimen-activated...

Roche Diabetes Care. (Product Briefs).
September 12, 2002... Roche Diabetes Care (Basel, Switzerland) demonstrated at last week's European Association for the Study of Diabetes meeting in Budapest, Hungary, its Accu-Chek brand products, including the Accu-Chek Compact Blood Glucose Monitoring System,...

Government agency suggests diagnostic osteoporosis testing.
September 19, 2002... There is little question that osteoporosis is a frightening reality for aging women. This week, the government is weighing in on the bone-thinning disease. A report released by the Agency for Healthcare Research and Quality (AHRQ;...

Allergic reactions to contrast media probed by researchers. (Report from Europe).
September 19, 2002... Although allergic reactions to contrast media are uncommon, they may be severe and even life-threatening, according to Professor Olivier Clement of the department of radiology at the Hopital Europeen Georges Pompidou (Paris). He recently...

In vitro devices to get new `one-stop shop' FDA office.
September 19, 2002... WASHINGTON -- Manufacturers of in vitro diagnostic devices (IVDs) will notice a pleasant change at the FDA this fall. The Center for Devices and Radiological Health (CDRH) at the FDA has announced that it will establish a new office-level...

Visible Human effort promises more detailed 3-D simulation.
September 19, 2002... AURORA, Colorado -- Coming soon to a website near you--the most accurate anatomical representation yet of the human female. While this may sound like the latest porn site come-on, it is, rather, a very direct scientific offering promised by...

Population genetics drives Peoples Genetics' platform.
September 19, 2002... Peoples Genetics (Woburn, Massachusetts) Chief Operating Officer Kevin Molloy describes the company's challenge as being a little like looking for a needle in a haystack. That challenge is finding disease-causing gene mutations in large...

More insurers cover FirstCyte. (Briefly Noted).
September 19, 2002... Cytyc (Boxborough, Massachusetts) said three additional health insurers approved coverage for FirstCyte Ductal Lavage technology to aid in breast cancer risk assessment. The added health plans are Trigon Blue Cross Blue Shield, the largest...

Platinum Equity buys Philips radiology-related business. (Deals roundup).
September 19, 2002... Royal Philips Electronics (Amsterdam, the Netherlands) reached a definitive agreement to sell its Healthcare Products Group (HCP; Cleveland, Ohio) unit to Platinum Equity Holdings (Los Angeles, California), a global acquisition firm. HCP...

Imagyn Medical Technologies (Irvine, California) signed a definitive agreement with Tyco Healthcare (Pembroke, Bermuda) to acquire all the assets related to Tyco's ABBI breast biopsy device. (Deals roundup).
September 19, 2002... Imagyn Medical Technologies (Irvine, California) signed a definitive agreement with Tyco Healthcare (Pembroke, Bermuda.) to acquire all the assets related to Tyco's ABBI breast biopsy device. The transaction is expected to close on Sept. 30....

US Diagnostic (USD; West Palm Beach, Florida) signed a definitive agreement to sell its diagnostic imaging business to DVI Financial Services (DVIFS). (Deals roundup).
September 19, 2002... US Diagnostic (USD; West Palm Beach, Florida) signed a definitive agreement to sell its diagnostic imaging business to DVI Financial Services (DVIFS), which, together with DVI Business Credit Corp., is the company's primary senior lender. ...

SpectRx to receive $1M from Abbott as milestone payment. (Financings roundup).
September 19, 2002... SpectRx (Norcross, Georgia) said Abbott Laboratories (Abbott Park, Illinois) agreed to make a $1 million milestone payment under a program to commercialize SpectRx's continuous glucose monitoring technology. Abbott and SpectRx are jointly...

Hypertension Diagnostics. (Financings roundup).
September 19, 2002... Hypertension Diagnostics (Eagan, Minnesota) has extended the period during which holders of the company's redeemable Class A warrants may participate in the company's offering of up to 2.36 million redeemable Class B warrants. The offering...

OraSure Technologies. (Financings roundup).
September 19, 2002... OraSure Technologies (Bethlehem, Pennsylvania) received from the Technology and Life Sciences Division of Comerica a $10.9 million credit facility, composed of a $4 million line of credit for working capital, a $3 million term loan, a $3...

Optical Sensors (OSI; Minneapolis, Minnesota) reported a 1-for-6 reverse split of its common stock, along with a new ticker symbol, OPTL. (Financings roundup).
September 19, 2002... Optical Sensors (OSI; Minneapolis, Minnesota) reported a 1-for-6 reverse split of its common stock, along with a new ticker symbol, OPTL. OSI is focused on low-cost, fiber optic sensors, instruments and pilot plant manufacturing, with the...

Cardiovascular profiling in China. (Briefly Noted).
September 19, 2002... Hypertension Diagnostics (HDI; St. Paul, Minnesota) said its chief medical consultant, Jay Cohn, would speak at the Great Wall International Conference of Cardiology in Beijing, China, to discuss the company's CVProfilor DO-2020 CardioVascular...

Aviva Biosciences. (People in Places).
September 19, 2002... * Norrie Russell, PhD, was appointed president and CEO of Aviva Biosciences (San Diego, California), a developer of biochip technologies for drug discovery and diagnostics. He succeeds Peter Wilding, PhD, who will become chairman. Charles Sie,...

Bio-Reference Laboratories. (People in Places).
September 19, 2002... * John Littleton was named vice president of sales for Bio-Reference Laboratories (Elmwood Park, New Jersey). Littleton's experience includes more than four years building the sales force at Specialty Laboratories, and before that as Northeast...

OraSure Technologies. (People in Places).
September 19, 2002... * Joseph Zack was appointed vice president of marketing and sales at OraSure Technologies (Bethlehem, Pennsylvania). He previously held the same position at OraPharma. OraSure Technologies is a developer of oral fluid diagnostics.

A multipurpose clinical analyzer. (Report from Europe).
September 19, 2002... Maxmat (Montpellier, France) has launched in Europe its Maxmat PL clinical chemistry system, a benchtop analyzer for smaller laboratories, but capable of running clinical chemistry, hemostatis, chronometric, chromogenic and ELISA testing all on...

Fluorescence microplate reader. (Report from Europe).
September 19, 2002... IOM (Berlin, Germany) has launched in Europe the LF401 Scan fluorescence reader which is claimed to combine the advantages of laser-induced fluorescence detection with a high throughput analysis capacity. A laser combination provides...

Trinity to transfer hemostasis production. (Report from Europe).
September 19, 2002... Trinity Biotech (Dublin, Ireland) plans to transfer the hemostasis diagnostics production acquired in its deal with Sigma Diagnostics (St. Louis, Missouri) to Ireland by early next year. The unit comprises a comprehensive reagent portfolio...

Oxagen eyes osteoporosis markers. (Report from Europe).
September 19, 2002... Oxagen (Abingdon, UK) in-licensed rights to three polymorphisms, each of which represents a diagnostic marker for the detection of predisposition to osteoporosis. The company said it has added significant value to the polymorphisms,...

Abbott Laboratories (Abbott Park, Illinois) said it anticipates that more breast cancer patients will benefit from use of its Vysis PathVysion fluorescence in situ hybridization (FISH) test as a result of the FDA's approval to include information about it in the labeling for Herceptin, a monoclonal antibody treatment for women with metastatic breast cancer. (Product Briefs).
September 19, 2002... * Abbott Laboratories (Abbott Park, Illinois) said it anticipates that more breast cancer patients will benefit from use of its Vysis PathVysion fluorescence in situ hybridization (FISH) test as a result of the FDA's approval to include...

Chemicon International. (Product Briefs).
September 19, 2002... * Chemicon International (Temecula, California), a provider of immunological and molecular biology reagents and tests, launched the ATA100 Advanced Tissue Arrayer. Designed and manufactured in collaboration with Advanced EDM Automation (Poway,...

Cygnus (Redwood City, California) and distribution partner, Sankyo Pharma (Parsippany, New Jersey) launched in the U.S. the GlucoWatch G2 Biographer. (Product Briefs).
September 19, 2002... * Cygnus (Redwood City, California) and distribution partner, Sankyo Pharma (Parsippany, New Jersey) launched in the U.S. the GlucoWatch G2 Biographer. The G2 is the second-generation model of the GlucoWatch Biographer, the first monitoring...

Given Imaging. (Product Briefs).
September 19, 2002... * Given Imaging (Yokneam, Israel) reported publication in this month's issue of Gastrointestinal Endoscopy of a study that concluded that its M2A capsule endoscope identified small intestinal bleeding sites beyond the range of push enteroscopy....

Ischemia Technologies. (Product Briefs).
September 19, 2002... * Ischemia Technologies (Denver, Colorado) said Canadian regulatory authorities granted marketing approval for its Albumin Cobalt Binding test, used to detect acute cardiac conditions in patients with chest pain. The test is available in...

Magna-Lab. (Product Briefs).
September 19, 2002... * Magna-Lab (Lynnfield, Massachusetts) received U.S. patent No. 6,437,569 with 33 claims for its Illuminator Probe, a non-invasive, expandable MRI receiving coil to advance the definitive diagnosis of coronary artery and other heart diseases....